瑞普生物 (300119.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(瑞普生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 533,199,134.682,248,962,053.981,587,164,776.49994,096,256.27442,780,482.142,084,250,399.001,476,760,957.48908,337,389.14390,806,576.59
 营业利润(元) 105,375,441.99565,230,235.97326,718,407.91215,890,268.2998,534,255.21416,638,427.72284,666,735.22168,772,958.2584,660,247.50
 利润总额(元) 105,078,491.84566,680,053.37326,085,531.64215,106,348.6898,183,331.71413,811,392.98284,933,854.10169,173,624.4085,516,256.66
 净利润(元) 93,504,682.67511,016,725.18294,900,963.96193,473,913.0087,502,825.62373,769,857.96256,016,202.77153,588,083.6079,588,705.19
 归属于母公司股东的净利润(元) 87,571,107.92452,942,064.27273,697,993.12178,271,133.7480,823,461.46346,698,684.97233,020,816.18139,832,575.9372,205,916.82
盈利能力:
 销售毛利率(%) 47.7349.6950.9551.9850.9848.4447.7148.4049.40
 销售净利率(%) 17.5422.7218.5819.4619.7617.9317.3416.9120.37
 净资产收益率(%) 1.9710.396.464.311.92----
 总资产报酬率ROA(%) 1.749.225.493.741.77----
 投入资本回报率ROIC(%) 1.558.445.293.441.576.944.642.861.50
营运能力:
 存货周转率(次) 0.702.992.081.260.57----
 应收账款周转率(次) 0.642.671.961.340.65----
 总资产周转率(次) 0.080.350.260.170.08----
偿债能力:
 资产负债率(%) 26.7027.1525.2925.6823.9526.2929.0127.1722.36
 股东权益比率(%) 68.5868.1770.1369.7571.3869.1366.5468.2672.96
 已获利息倍数(倍) 21.7130.9223.7424.1520.1324.8625.8126.1241.00
 流动比率 2.742.432.662.662.602.362.182.312.84
 速动比率 2.402.112.302.272.222.061.892.002.44
发展能力:
 营业收入增长率(%) 20.427.907.489.4413.303.84-1.48-12.72-30.20
 营业利润增长率(%) 6.9435.6614.7727.9216.39-16.57-21.09-33.85-44.70
 税后利润增长率(%) 8.3530.6417.4627.4911.93-16.01-20.25-31.32-37.94
 净资产增长率(%) 6.186.516.096.214.994.6858.5560.3859.25
 总资产增长率(%) 10.528.020.653.937.327.3050.1243.8935.44

前瞻产业研究院